Hem › Hypofarynxcancer › Pennsylvania › Philadelphia
Kliniska studier för Hypofarynxcancer i Philadelphia, PA
3 studier för Hypofarynxcancer söker deltagare vid platser i och runt Philadelphia (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
RekryterarFas 2
- Thomas Jefferson University Hospital, Philadelphia
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
RekryterarFas 2
- Fox Chase Cancer Center, Philadelphia
- Temple University Hospital, Philadelphia
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
RekryterarFas 3
- Christiana Care Health System-Concord Health Center, Chadds Ford · 23 mi bort
- Christiana Care Health System-Wilmington Hospital, Wilmington · 25 mi bort
Hypofarynxcancer-studier i andra städer
- Atlanta, GA6 studier
- Chicago, IL6 studier
- Richmond, VA5 studier
- Kansas City, MO5 studier
- Cape Girardeau, MO5 studier
- Bloomington, IL5 studier
- Milwaukee, WI5 studier
- Stevens Point, WI5 studier
- Joliet, IL5 studier
- Peoria, IL5 studier
- Wausau, WI5 studier
- Cincinnati, OH4 studier
Andra studier i Philadelphia
- Cancer (alla typer)59 studier
- Bröstcancer56 studier
- Icke-småcellig lungcancer51 studier
- Metastaserande cancer46 studier
- Prostatacancer44 studier
- Kolorektal cancer44 studier
- Äggstockscancer44 studier
- Lungcancer36 studier
- Akut myeloid leukemi34 studier
- Hjärtsvikt31 studier
- Endometriecancer28 studier
- Depression26 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.